Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Jan 02, 2024 | Option Exercise | $2.28 | 161 | 367 | 149,435 | Jan 03, 2024, 05:20 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Oct 02, 2023 | Option Exercise | $3.83 | 1,154 | 4,420 | 24,596 | Oct 04, 2023, 04:21 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | May 31, 2023 | Option Exercise | $3.46 | 3,664 | 12,664 | 25,907 | Jun 02, 2023, 04:34 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Mar 20, 2023 | Buy | $2.50 | 10,000 | 25,000 | 22,721 | Mar 22, 2023, 04:01 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Dec 31, 2022 | Option Exercise | $0.15 | 1,813 | 272 | 229,144 | Jan 04, 2023, 05:12 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Sep 30, 2022 | Option Exercise | $0.22 | 1,813 | 404 | 230,957 | Oct 04, 2022, 05:04 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Jun 30, 2022 | Option Exercise | $0.39 | 1,813 | 705 | 232,770 | Jul 05, 2022, 05:00 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Mar 31, 2022 | Option Exercise | $0.65 | 3,630 | 2,359 | 234,583 | Apr 04, 2022, 05:09 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Dec 31, 2021 | Option Exercise | $1.02 | 1,484 | 1,514 | 163,213 | Jan 04, 2022, 04:40 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Sep 30, 2021 | Option Exercise | $1.39 | 1,484 | 2,063 | 164,697 | Oct 01, 2021, 05:11 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Jun 30, 2021 | Option Exercise | $3.51 | 3,551 | 12,464 | 105,322 | Jul 02, 2021, 04:36 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Mar 31, 2021 | Option Exercise | $6.84 | 1,765 | 12,073 | 108,873 | Apr 02, 2021, 12:14 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Dec 31, 2020 | Option Exercise | $1.58 | 1,822 | 2,879 | 325,703 | Jan 05, 2021, 12:00 AM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Nov 30, 2020 | Option Exercise | $1.45 | 10,460 | 15,115 | 327,525 | Dec 02, 2020, 04:31 PM | |
VYNE | VYNE Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Sep 30, 2020 | Option Exercise | $1.66 | 1,822 | 3,025 | 317,065 | Oct 02, 2020, 04:31 PM | |
MNLO | Menlo Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Jun 30, 2020 | Option Exercise | $1.73 | 1,822 | 3,152 | 318,887 | Jul 02, 2020, 04:24 PM | |
MNLO | Menlo Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Apr 06, 2020 | Option Exercise | $1.40 | 4,474 | 6,264 | 170,712 | Apr 07, 2020, 05:22 PM | |
MNLO | Menlo Therapeutics Inc. | Harsch Mutya | Chief Legal Officer and GC | Mar 31, 2020 | Option Exercise | $2.68 | 1,688 | 4,524 | 56,503 | Apr 02, 2020, 04:47 PM | |
FOMX | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Mar 02, 2020 | Option Exercise | $2.68 | 1,761 | 4,715 | 98,232 | Mar 03, 2020, 12:00 AM | |
FOMX | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Dec 31, 2019 | Option Exercise | $3.28 | 618 | 2,027 | 55,172 | Jan 03, 2020, 05:23 PM | |
FOMX | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Nov 29, 2019 | Option Exercise | $2.16 | 4,284 | 9,249 | 55,790 | Dec 03, 2019, 04:30 PM | |
FOMX | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Sep 30, 2019 | Option Exercise | $3.07 | 463 | 1,421 | 51,506 | Oct 02, 2019, 04:19 PM | |
FOMX | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Jul 01, 2019 | Sale | $2.35 | 639 | 1,502 | 51,969 | Jul 03, 2019, 04:28 PM | |
FOMX | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Apr 01, 2019 | Sale | $3.75 | 2,519 | 9,446 | 52,608 | Apr 03, 2019, 04:42 PM |